# Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine

> **NCT01629329** · PHASE4 · TERMINATED · sponsor: **Albert Einstein Healthcare Network** · enrollment: 93 (actual)

## Conditions studied

- Migraine Headaches

## Interventions

- **DRUG:** Aspirin, Acetaminophen, Caffeine pills
- **DRUG:** Prochlorperazine 10mg

## Key facts

- **NCT ID:** NCT01629329
- **Lead sponsor:** Albert Einstein Healthcare Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2014-04
- **Final completion:** 2014-07
- **Target enrollment:** 93 (ACTUAL)
- **Why stopped:** no difference found between two groups in a preliminary analysis
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01629329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01629329, "Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01629329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*